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Engineering, University of California, Berkeley, CaliforniaABSTRACT Using a coarse-grained lipid and peptide model, we show that the free energy stabilization of amyloid-b in hetero-
geneous lipid membranes is predicted to have a dependence on asymmetric distributions of cholesterol compositions across the
membrane leaflets. We find that a highly asymmetric cholesterol distribution that is depleted on the exofacial leaflet but
enhanced on the cytofacial leaflet of the model lipid membrane thermodynamically favors membrane retention of a fully
embedded Ab peptide. However, in the case of cholesterol redistribution that increases concentration of cholesterol on the exo-
facial layer, typical of aging or Alzheimer’s disease, the free energy favors peptide extrusion of the highly reactive N-terminus into
the extracellular space that may be vulnerable to aggregation, oligomerization, or deleterious oxidative reactivity.INTRODUCTIONAlois Alzheimer, in his original 1907 report on the pathol-
ogies he observed of the brain of deceased patient Auguste
Deter, noted three markers for the degenerative disease (1).
Two of the markers of Alzheimer’s disease (AD) are the now
well-known presence of insoluble extracellular plaques con-
taining the Ab peptide and intracellular tangles that also
incorporate the hyperphosphorylated Tau protein (2–4).
These compelling features have led to many decades of
long investigations devoted to refining our knowledge about
these deposits, the possible origins of the cytotoxicity of the
insoluble aggregates or their soluble precursors (4), and the
continued search for therapeutics that mitigate their cyto-
toxic effects (5,6). However, a third pathological marker
for AD noted by Alzheimer in his early study was the pres-
ence of lipoid granules that is now recognized as a symptom
of aberrant lipid metabolism (1,2).
The disease implications for this third pathology for Alz-
heimer’s have only become prominent over the last decade
(2) and arise from several well-supported observations
(3,4): the one definitive genetic marker for AD involves mu-
tation of apolipoprotein E (ApoE) that is responsible for lipid
transport and cholesterol regulation; many of the proteins in-
dicted inAD are transmembrane proteins such as the amyloid
precursor protein (APP) as well as a-, b-, and g-secretases
that cleave APP to yield various peptide products including
Ab; and finally the fact that aggregation of Ab and possibly
Tau is mediated by the cell membrane environment (3).
Recent NMR, chromatography, and mass spectrometry
studies have examined how lipid composition changes in
neuronal cell membranes of Alzheimer’s patients, noting a
significant loss of phosphatidyl-ethanolamine (PE) and a va-
riety of sphingolipids such as sulfatides and ceramides (7).Submitted April 6, 2013, and accepted for publication June 7, 2013.
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0006-3495/13/08/0899/12 $2.00The newly emergent field of lipidomics (8) is allowing for
large-scale measurements of lipid compositions and/or their
spatial/temporal arrangements in the cell membrane of
various tissues. Relevant to this work is that such measure-
ments provide information on lipid membrane compositions
of brain matter as a function of aging (9–13) or induced by
the degenerative AD state (7). For example, aging rat brain
cells show a redistribution of cholesterol toward greater
accumulation onto the exoplasmic leaflet of the synaptic
plasma membrane (SPM) (14,15). In the aging human brain
(aging being a primary factor in AD) there is a marked loss
or gain of various gangliosides (10,11), and redistributions
of phospholipids and cholesterol across the bilayer leaflets
are thought to negatively impact neuronal membrane func-
tion (16). Modifications of cholesterol distributions in
neuronal plasma membranes may especially be relevant
for neurodegenerative diseases of aging such as Alzheimer’s
and Parkinson’s (17). For example, a ~30% decrease in the
molar ratio of cholesterol/phospholipid with respect to
healthy levels (18) and cholesterol redistribution in the
membrane (16,17) are hypothesized to be predisposition
factors to AD because they are a consequence of aging,
the primary factor in developing the disease, and they corre-
late with overexpression or aberrant activity of ApoE
(14,19), whose function is to transport cholesterol across
the membrane leaflets.
In this work we model the lipid compositions based on a
combination of two different experimental studies of lipid
compositions of the SPM from rats and mice. Cotman and
co-workers (20) assayed the composition of rat SPM using
chromatography to characterize the concentration and types
of phospholipids as well cholesterol across the lipid bilayer.
Their data showed that 62% of the lipid content of the SPM
consists of neutral saturated phosphatidylcholine (PC) and
unsaturated PE lipids, 12% negatively charged phosphati-
dylserine (PS) and phosphatidylinositol lipids, and ahttp://dx.doi.org/10.1016/j.bpj.2013.06.046
TABLE 1 Number and type of each lipid and solvation
molecules simulated for each type of bilayer; variations arise
due to small differences in simulation box volume
Lipid bilayer model Leaflet POPC DOPE POPS Cholesterol
40% cholesterol concentration Exo 60 47 3 33
30% exo/70%cyto Cyto 28 24 27 100
40% cholesterol concentration Exo 58 47 3 40
40% exo/60%cyto Cyto 30 24 27 93
20% cholesterol concentration Exo 44 47 3 24
50% exo/50%cyto Cyto 44 27 27 24
40% cholesterol concentration Exo 44 47 3 66
50% exo/50%cyto Cyto 44 24 27 66
80% cholesterol concentration Exo 44 47 3 376
50% exo/50%cyto Cyto 44 24 27 380
No sterol Exo 120 25 3 0
Cyto 27 96 24 0
900 Liguori et al.small percentage (~3%) of sphingomyelin. The predominant
sterol is found to be cholesterol, comprising over 18% of the
membrane (by mass). It has long been known that the phos-
pholipids are unevenly distributed between the exofacial
(exo) and cytofacial (cyto) leaflets of the membrane, with
the cyto one being negatively charged (by virtue of
including most of the PS), whereas the exo leaflet is approx-
imately neutral. Somewhat more recently, Igbavboa et al.
(15) showed there is an age-dependent distribution of
cholesterol between the SPM leaflets, which they measured
at four different stages of life. Young mice (~3–4 months)
were reported to have the total cholesterol distributed asym-
metrically at 15% along the exo plane, with the remaining
85% accumulated along the cyto leaflet (15%/85% exo/
cyto); these values change during life and level off at a
mature stage to reach a roughly 50%/50% exo/cyto distribu-
tion (15).
Here, we investigate how different lipid compositions in-
crease or decrease the free energy of lipid bilayer incorpora-
tion of the Ab42 peptide, and whether it is the asymmetry or
the amount of cholesterol that matters for the positioning of
the Ab peptide in the membrane. We use coarse-grained
(CG) representations of Ab42 assuming that it has an overall
helical percentage of 70% or 30%, and lipid bilayers
composed of phosphatidylcholine (POPC), phosphatidyl-
ethanolamine (DOPE), phosphatidylserine (POPS), and
cholesterol. Given the small percentages of measured
phosphatidylinositol and sphingomyelin (20), and the finite
bilayer area we have simulated, their number representa-
tions are negligible and therefore were ignored in our study.
The spatial composition of the lipids are organized so that
they reproduce age-dependent asymmetries in cholesterol
distributions between the inner and outer membrane leaflets,
and we compare them to controls that vary the cholesterol
percentage while keeping it symmetrically distributed
across the two leaflets, or with no cholesterol at all.
We find that the reduced concentrations of cholesterol in
the exofacial leaflet, the membrane model closest to that of
young neuronal cells in rodents, favors membrane retention
of the highly reactive N-terminus region of the Ab peptide
with the C-terminus exposed to the cytosol. By contrast, de-
creases in the cholesterol content of the cyto leaflet, cor-
responding to the SPM of aged individuals, favor
repositioning of the Ab42 C-terminus to the exo leaflet,
with the first 28 residues of the Ab42 peptide collocated
to the extracellular space. Elimination of cholesterol alto-
gether (an extreme case of the depletion of cholesterol as re-
ported for AD patients (18)), no longer stabilizes any part of
the Ab42 peptide in the membrane, and instead the entire
peptide is stabilized on the membrane surface. These results
are dependent on the condition that the C-terminal residues
of Ab42 adopt helical structure, which would be expected
for a peptide with the glycine-X-X-X-glycine motif that is
observed for other transmembrane proteins and peptides
that adopt an a-helix structure inside a membrane (21).Biophysical Journal 105(4) 899–910Our work shows that small variations in cholesterol asym-
metries (~10% molar fraction per leaflet) can strongly influ-
ence the thermodynamics of Ab peptide exposure to the
extracellular solvent.MODELS AND METHODS
Model membrane compositions and peptide
structure
We used the MARTINI 2.0 model (22) for all the lipids,
cholesterol, Ab42 peptide, ions, and water, and molecular
dynamics (MD) simulations of the CG model were per-
formed using GROMACS 4.5.4 (23). Six planar lipid bila-
yers were created with composition percentages of POPC,
DOPE, POPS, and cholesterol chosen to reproduce reason-
able models of heterogeneous SPM lipid compositions in
[(20)] and [(15)], and including some additional controls,
which are listed in Table 1. The overall cholesterol concen-
tration (compared to all of the lipids in the membrane) var-
ied between 0% and 80%, and the cholesterol was
distributed symmetrically or asymmetrically for a given
concentration. Although it is estimated that typical mem-
branes are composed on average of equal percentages of
proteins and a variety of lipids, if we consider our small sur-
face of ~100 nm2 in area compared to the total neuronal cell
diameter that varies from 0.4 to 100 mm, we can legitimately
model the subdomain as a planar bilayer devoid of multiple
protein constituents.
The most physiologically relevant lipid bilayers we stud-
ied had an overall cholesterol concentration of 40%, in
which cholesterol was varied asymmetrically or symmetri-
cally across the exo and cyto leaflets, consistent with the
SPM changes with age studied by Igbavboa and co-workers
(15). We note that it was not possible to stabilize a planar
bilayer model of the 15%/85% exo/cyto asymmetry (corre-
sponding to the earliest stage of life for mice SPM), in which
the membrane exhibited high curvature (24). The appear-
ance of high curvature due to heterogeneous or asymmetric
membranes formed by different sizes/lengths of lipid
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was largely found to be independent of the ensemble used.
Nonetheless, we were able to produce stable planar bilayers
with a total cholesterol concentration of 40% and distribu-
tions of 30%/70% and 40%/60% exo/cyto asymmetry. To
be consistent in our analysis of a given cholesterol compo-
sition for the asymmetric distributions at 40% concentra-
tion, we fixed the total number of all lipids, and changed
just the partitioning of cholesterol and POPC to maintain
a constant surface area of the membrane; we note that the
molecular weight of cholesterol is roughly half that of other
phospholipids. Although other choices are possible, this
approach also kept the PS numbers constant to ensure the
basic electrostatic configuration of the membrane (inner
leaflet ¼ negative, outer leaflet ¼ roughly neutral) was
maintained. We also considered additional controls of
planar lipid bilayers with symmetric distributions of 20%
and 80% cholesterol concentration, as well as no cholesterol
at all.
We have focused most of our calculations on the reason-
able expectation that a single Ab42 peptide is predominately
(~70%) helical in a lipid bilayer environment, although an
additional control was considered that lowered helical con-
tent to just 30%. Coordinates for Ab42 with 70% helical
content were obtained from structure 1IYT (25), in which
the peptide is solvated in an apolar environment that mimics
the membrane interior. The structure was converted to the
MARTINI CG secondary structure assignment using Dictio-
nary of Secondary Structure of Proteins (DSSP) (26):
TTSSSTTHHHHHHHHHHHHHHHHHHTTHHHHHHHH
HHHHSTT. (In DSSP the secondary structure abbrevia-
tions are: H ¼ a-helix, S ¼ bend, and T¼ hydrogen-bonded
turn.) It should be noted that the secondary structure is
immutable in the MARTINI force field once specified and
subsequently the helical regions do not change when
simulated under thermal motion or altered membrane
environments (although the low dihedral barriers for the
turn regions are more flexible). Therefore, we also consid-
ered an alternative secondary structure profile for Ab42 in
which the overall a-helical content was reduced to 25–
30%, and was manifested as the secondary assignment of:
TTSSTTTTTTHHHHHHHHHHHTTTTTTSGGGSSSSTT
SSTTT based on Protein Data Bank structure 1Z0Q (27).
(The additional DSSP abbreviation here is G ¼ 310-helix.)
Note that the two alternative structures differ primarily in
whether the C-terminus adopts a helical domain.Simulation protocols
To produce the initial configurations of the model bilayers
both with and without the Ab42 peptide, we used Packmol
(28). For the systems containing Ab42, the system was built
with the helical peptide inserted with its longitudinal axis
parallel to the membrane axis (vertical position). We chose
simulation box sizes that allowed for ~30 CG water mole-cules per lipid, equivalent to hydrating each phospholipid
with >120 all-atom water molecules. We added Naþ and
Cl ions to reproduce the physiological salt concentration
of 150 mM, with additional Naþ to neutralize the overall
negative net charge of the bilayer, and used a relative dielec-
tric constant of 15. We then performed 4000 steps of steep-
est descent minimization, and then carried out two ~3 ms
NPgT simulations (constant surface tension g ¼ 0) at T ¼
298.15 K and at T ¼ 323.15 K—each with periodic bound-
ary conditions. The purpose of conducting simulations at
two temperatures was to produce controls that studied the
difference in the mobility of the peptide between 298 and
323 K. We chose a time step of 20 fs for all of the unbiased
simulations. To ensure a constant temperature, we coupled
the lipids and water (including counterions) separately using
a Bussi velocity rescaling thermostat (29) with a time
constant tT¼ 0.3 ps for each coupling group. To ensure con-
stant pressure and surface tension, we used a semiisotropic
Berendsen barostat (30) with a time constant tP¼ 3 ps, pres-
sure of 1.0 bar, and compressibility of 3  105 bar1. In
addition, we chose shifted nonbonded potentials in the range
0–1.2 nm (Coulomb) and 0.9–1.2 nm (van der Waals). We
constrained all the lengths of the bonds via the Lincs algo-
rithm (31). All other analyses (and the biased simulations
described below) were performed on the systems produced
at 323 K, a temperature that was purposefully chosen to
be above the gel-to-liquid phase transition for all of the
phospholipids included in our bilayers.
For the asymmetric cholesterol distribution the initial
conditions of exo/cyto cholesterol distributions were 25%/
75% and 30%/70% which equilibrated to a concentration
of 30%/70% and 40%/60%, respectively. The symmetric
distributions equilibrated to cholesterol distributions consis-
tent with their initial conditions. We calculated the diffusion
coefficient from the Einstein relation based on the mean
square displacement. We limited the calculation to the outer
leaflet, because we were primarily interested in the changes
of fluidity that occur within the exo region through which
the Ab peptide is released. We considered a number of addi-
tional controls: two symmetric bilayers (20% and 80% total
cholesterol concentration) and two bilayers in which Ab42
was assigned an alternate secondary structure (described
previously). For these controls, the simulation protocols
were the same as previously described, but the equilibration
and production simulations were run only at 323 K (~3 ms).
To calculate the free energy as a function of the distance
between the center of mass of the peptide and of the overall
lipid bilayer, we used an umbrella sampling method consis-
tent with the one used by Lemkul and Bevan (32). Initial
snapshots for the umbrella sampling windows were gener-
ated by performing steered MD (SMD) simulations in which
the center of mass of the peptide was pulled along the z axis
from within the membrane out into solvent. A schematic of
the simulation setup is depicted in Fig. 1. The pulling rates
used in the SMD simulations varied from 0.05–0.60 nm/ns,Biophysical Journal 105(4) 899–910
FIGURE 1 Representative schematic of the simulation setup depicting
Ab42 (red) plus a lipid bilayer (orange) system. The green dotted lines
define the distance between the centers of mass of the peptide and of the
overall lipid bilayer, used as the reaction coordinate for the computation
of the free energy. The yellow arrow indicates the direction of the pulling
force vector to generate the starting snapshots for the umbrella sampling
windows.
902 Liguori et al.and the force constants used varied from 1000–
8000 kJ/mol/nm2. The umbrella sampling windows were
separated by ~1 A˚ along the reaction coordinate, resulting
in 23–46 windows for each peptide-membrane system de-
pending on cholesterol content. Individual umbrella simula-
tions ranged in length from 525 to 1800 ns, resulting in total
simulation times ranging from 12 to 60 ms. The umbrella
sampling simulations used a simple harmonic potential to
maintain the system within the specified range of the reac-
tion coordinate. In both the SMD simulations and umbrella
sampling simulations, we sampled with integration steps
ranging between 0.01 and 0.02 ps and made use of the
Nose´-Hoover thermostat (33,34) and Parrinello-Rahman
barostat (35,36) using coupling constants tT ¼ 4 ps and
tP ¼ 4 ps, respectively. The reaction coordinate histograms
were obtained by excluding the first 300 ns of each umbrella
window simulation (i.e., treating this time as the equilibra-
tion period). These were then converted into free energy
profiles using WHAM (23,37), and respective error bars
were computed via bootstrapped trajectories based on the
umbrella histograms (37). Specifically, the histograms of
the umbrella sampling windows were used to create newTABLE 2 Values of bilayer thickness for all the bilayers at each tem
Temperature Peptide
Bilayer 30%/70% exo/cyto (40%
cholesterol concentration) (nm)
Bilayer 40%/60%
cholesterol conce
298 K No 4.7485 0.050 4.6655
Ab 4.5245 0.058 4.4305
323 K No 4.6475 0.028 4.5925
Ab 4.4265 0.011 4.3805
To quantify bilayer thickness to compare to an electron (or a mass) density pro
belonging to the phospholipids headgroup regions of the asymmetrical choleste
distance and standard deviation were taken over three different blocks of trajec
Biophysical Journal 105(4) 899–910random (reaction coordinate versus time) trajectories with
the appropriate probability distributions and autocor-
relation times. For each pmf, we generated 50 such
bootstrapped trajectories, and the error bars shown are the
standard deviations of the bootstrapped pmfs from the
average pmfs (which in the limit of an infinite number of
bootstrapped trajectories would be identical to the original
pmfs (37)).RESULTS
Membrane thickness and diffusion
Table 2 presents the results on bilayer thickness for the 40%
total cholesterol bilayers, in which we found values between
4.2 and 4.7 nm, in excellent agreement with the experi-
mental data generated from neutron (38) and x-ray diffrac-
tion (39) and the expected dependence on temperature.
Nevertheless, our heterogeneous membranes in the presence
of 70% helical Ab resulted in a small but measureable thin-
ning of the different membranes, averaged over the whole
membrane patch, except for the symmetric (i.e., 50%/50%
exo/cyto) cholesterol distribution in which the difference
is within the uncertainties of the calculation. It is interesting
to note that a general thinning of neuronal membrane has
been observed in AD patients as compared to healthy sub-
jects (18), and another study documented a membrane thin-
ning associated with the introduction of Ab (40,41).
However, the much smaller (nearly order of magnitude) dif-
ferences in membrane thinning we observe in this study are
certainly due to the low Ab42 concentration and higher
cholesterol/lipid molar ratio used here compared to these
previous experiments. Although we cannot directly make
connections between our results and these other disease
studies (40,42), it does bring up an important point about
the interpretation of those measurements. In particular, the
membrane thickness is not uniform over the entire patch
as we will see from the radial distribution functions pre-
sented below, and those variations differ depending on
cholesterol content and distribution. For example, for the
symmetric cholesterol distribution we find that the sterol
and lipids significantly enhance their local density near
the peptide that results in a measurable thickening, even
when averaged over the whole membrane patch.perature
exo/cyto (40%
ntration) (nm)
Bilayer 50%/50% exo/cyto (40%
cholesterol concentration) (nm) No cholesterol (nm)
0.019 4.5415 0.014 4.5385 0.006
0.086 4.6665 0.032 4.3825 0.024
0.039 4.4595 0.049 4.5305 0.100
0.038 4.5415 0.075 4.4655 0.033
file, we measure at different temperatures the distance between the peaks
rol containing bilayers and of the bilayer without cholesterol. The average
tories, each consisting of 250 ns of simulation time.
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lipids belonging to the exo leaflet, which range from 7–90
1012 m2/s depending on temperature (298 or 323 K) and
whether 70% helical Ab42 and/or cholesterol is present.
The simulations reproduce the expected diffusion enhance-
ment trends with increasing temperature and the experi-
mental observation that above a ~30% mole fraction of
cholesterol the lipid lateral diffusion is consistently reduced
by a factor of 2–3 (43). In the presence of Ab42 at 323 K,
however, we find a small increase in the lateral diffusion co-
efficients for the 30%/70% and 40%/60% exo/cyto choles-
terol distributions, consistent with previous quasielastic
neutron scattering data on Ab25–35 in DMPC/DMPS mem-
branes (44) that showed an increase in lipid mobility caused
by the interaction between the bilayer and the Ab peptide it-
self. In fact comparing our results to that study (44), which
measured lateral lipid diffusion coefficients of 50–180
1012 m2/s over a range of 290–320 K for membranes
without cholesterol, our determined values of 7–90 
1012 m2/s over the same temperature range and with
cholesterol, and given that the MARTINI CG model
dynamics are usually faster, appear reasonable. The one
exception is that the lipid lateral diffusion coefficient
decreased in the presence of the Ab peptide for the 50%/
50% exo/cyto, in good agreement with an atomistic MD
study (45) that simulated the Ab42 monomer embedded in
a bilayer composed of only POPC with symmetrically
distributed cholesterol at a 40% concentration. This result
is due to the strong interactions of the peptides with choles-
terol and lipids, consistent with the membrane thickening
results at the same cholesterol conditions described previ-
ously, and which we analyze in more detail below.Free energy profiles
The free energy trends of the positioning of Ab42 in the het-
erogeneous bilayer as a function of cholesterol concentra-
tion and asymmetry is evaluated along a reaction
coordinate, DCOM, which is the distance between the center
of mass of the bilayer and the center of mass of the vertically
inserted Ab42 peptide. Near complete burial of the peptide
in the lipid bilayer occurs when DCOM ~0 nm, and progres-
sively greater extrusion of the Ab42 peptide into the extra-
cellular space corresponds to DCOM > 0 nm. Umbrella
sampling was used to examine the free energy change forTABLE 3 Values of exofacial phospholipid lateral diffusion coeffic
Temperature Peptide No cholesterol (1011 m2/s)
Bilayer 30%/70% exo/c
(40% cholesterol concentr
(1011 m2/s)
298 K No peptide 4.16(50.81) 1.12 (50.85)
Ab 3.17(50.14) 1.56 (50.74)
323 K No peptide 6.58(50.26) 2.59 (50.26)
Ab 9.13(51.45) 4.21 (50.55)
Errors computed from the standard deviations from the linear fit in the range 7the Ab42 peptide initially embedded in the lipid bilayer at
DCOM ¼ 0 nm and as it progresses along the reaction coor-
dinate toward the exo side for each lipid bilayer membrane
composition (see Methods).
We first discuss the potential of mean force results on the
physiologically relevant lipid bilayer with 40% cholesterol
concentration, but in which the cholesterol is distributed at
30%/70%, 40%/60%, and 50%/50% in the exo/cyto leaflets.
We also only consider the 70% helical Ab42 that adopts
helical domains in both the N-terminus and C-terminus of
the peptide. Fig. 2 a shows that a highly asymmetric choles-
terol distribution in the membrane—one consistent with the
sterol distributions observed in young mice SPMs—thermo-
dynamically favors the nearly full embedding of the Ab42
peptide at DCOM ~0 nm, with a favorable binding free en-
ergy of ~40 kJ/mol compared to the completely released
peptide at DCOM ~3.0 nm. When we evaluate the solvent
accessible surface area (SASA) of the peptide to water at
the free energy minimum (DCOM ~0 nm), we find that the
N-terminal region of the peptide largely remains protected
from the extracellular space (exposing only the first six res-
idues), although the C-terminus of the peptide is solvent
exposed on the cytosol side of the model membrane
(Fig. 3 a).
By contrast for the 40%/60% and 50%/50% exo/cyto
cholesterol partitioning, shown to be typical of an aging
individual (15), the peptide thermodynamically favors
displacement toward the exo side. For the 40%/60% exo/
cyto partitioning the new global free energy minimum is
at DCOM ~1.75 nm (Fig. 2 b) and the binding free energy
for complete burial of Ab42 (i.e., at DCOM ~0 nm) is now un-
favorable by ~50 kJ/mol. At the global free energy minimum
for the 40%/60% exo/cyto cholesterol partitioning, the
SASA plot in Fig. 3 b shows that the first 28 residues of
the N-terminus of the peptide are exposed to the membrane
exo membrane surface and aqueous solvent. When 40% to-
tal cholesterol is distributed symmetrically across the two
leaflets (i.e., 50%/50% exo/cyto partitioning), Ab42 is
further displaced toward the exo side at DCOM ~1.75–
2.0 nm with a binding free energy that now irreversibly fa-
vors the N-terminus of the peptide to be collocated outside
the exo leaflet of the membrane (Fig. 2 c). In this case, the
first 28 residues of the N-terminus of the peptide are again
exposed to the exo membrane surface and aqueous solvent,
similar to that seen for 40%/60% exo/cyto in Fig. 3 b.ient DL
yto
ation)
Bilayer 40%/60% exo/cyto
(40% cholesterol concentration)
(1011 m2/s)
Bilayer 50%/50% exo/cyto
(40% cholesterol concentration)
(1011 m2/s)
1.33(50.42) 1.83 (50.59)
1.33(50.96) 0.73 (50.05)
2.63(50.65) 2.65 (50.88)
4.28(51.63) 2.01 (50.24)
0–400 ns.
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FIGURE 2 Free energy profile at 323 K as a function of the distance be-
tween the centers of mass of the 70% helical Ab42 peptide and lipid bilayer
(DCOM), for 40% total cholesterol. (a) The most asymmetric 30%/70% exo/
cyto cholesterol distribution consistent with the SPM of a young individual.
The global free energy minimum corresponds to the near complete burial of
the peptide in the membrane (DCOM ~0 nm) with C-terminus exposed to the
cytosol. (b) The asymmetric 40%/60% exo/cyto cholesterol distribution,
consistent with the SPM of an aging individual, has a global free energy
minimum in which the N-terminus of Ab42 strongly prefers exposure to
the extracellular region and to the membrane surface (DCOM ~1.75 nm).
Biophysical Journal 105(4) 899–910
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perspective of whether it is the asymmetry of cholesterol
distribution that matters, or whether it depends more on
absolute cholesterol content. Fig. 4 shows the free energy
change as the 70% helical Ab42 peptide is pulled out of
the lipid bilayer toward the exo side for the symmetric
exo/cyto compositions of 20% and 80% total cholesterol,
and with no cholesterol at all. With the sterol present at
20% concentration (Fig. 4 a) and 80% concentration
(Fig. 4 b), Ab42 again thermodynamically favors displace-
ment toward the exo side at DCOM ~1.75–2.0 nm, similar to
the 40% cholesterol results. Because the free energy mini-
mum is largely the same for all of the symmetric cholesterol
distribution cases, the 20% and 80% SASA plots were found
to be largely equivalent to the 40% total cholesterol results
seen in Fig. 3 b, in which the first 28 residues of the N-ter-
minus of the peptide is exposed to the membrane exo sur-
face and aqueous solvent. When cholesterol is eliminated
altogether (Fig. 4 c), the dominant free energy minimum
is displaced to DCOM ~2.5 nm, corresponding to the fact
that neither the N-terminus nor the C-terminus of Ab42 is
anchored in the cyto leaflet of the lipid bilayer. Instead,
the peptide is fully released from the membrane to bind to
the membrane surface as assessed by the SASA plots shown
in Fig. 3 c. However, the peptide still shows a relatively
favorable free energy minimum with the peptide buried,
but in contrast to the 30%/70% exo/cyto results, the peptide
is positioned so that only the roughly first 10 residues are
solvent exposed and there is no C-terminus exposure to
the cytosol side as shown in Fig. 3 d.
Fig. 5 provides a representative snapshot at the dominant
free energy minimum of the very different positioning of the
Ab42 peptide observed in the lipid bilayer for the 30%/70%
and 40%/60% exo/cyto cholesterol partitioning, a mere 10%
difference in sterol distributions, and with no cholesterol at
all. In Fig. 6, we also provide a more quantitative description
of the density profile across the lipid bilayer for the head-
groups and tails of cholesterol, POPC, and POPS, as well
the N- and C-terminus of the Ab42 peptide. These data
are consistent with the trends seen in the SASA plots in
Fig. 3, a–d.
This trend is, however, is strongly dependent on the heli-
cal content of the Ab peptide. When we considered the 30%/
70% exo/cyto cholesterol partitioning but with loss of helic-
ity of the C-terminal domain of Ab42 (i.e., using secondary
structure based on 1Z0Q), the peptide exits the membrane
altogether as the free energy (Fig. S1 a in the Supporting
Material) and SASA plots (Fig. S1 b) make evident. This
is an equally important result that shows that helicity of
the C-terminal region of Ab42 is necessary for its retention(c) The symmetric 50%/50% exo/cyto cholesterol distribution consistent
with the SPM of the most mature individual. The free energy shows that
Ab42 N-terminus is irreversibly exposed to the extracellular region and
to the membrane surface.
a b
c d
FIGURE 3 SASA of 70% helical Ab42 residues
evaluated at the dominant minima for (a) 30%/
70% exo/cyto in which the C-terminus is exposed
to the cytosol, (b) 40%/60% exo/cyto in which the
first 28 residues of the N-terminus is solvent
exposed to the exo side of the membrane, (c) no
cholesterol and evaluated at the lower free energy
minimum where the entire peptide is fully exposed
to the membrane surface and solvent on the exo
side, and (d) no cholesterol and evaluated at the
relative free energy minimum where only the first
6 residues are exposed to solvent on the exo side
and no exposure on the cytosol side. The SASA
values were normalized by the maximum SASA
values obtained for the peptide alone (i.e., without
any other surrounding molecules). This enables us
to differentiate between residues with low SASA
due to the structure of the peptide and those with
low SASA due to burial within/contact with the
lipid membrane.
Embedding Ab42 in Heterogeneous Membranes 905in the lipid bilayer and that any loss of secondary structure
in this region will release the peptide into the extracellular
space.
To better understand what peptide-lipid interactions may
be stabilizing Ab42 at different positions in the bilayer, we
have examined the radial distribution functions (RDFs)
evaluated at the dominant free energy minimum for the
40% total cholesterol system with 30%/70%, 40%/60%,
and 50%/50% exo/cyto cholesterol partitioning, with no
cholesterol present, and the symmetrically distributed 20%
and 80% total cholesterol membranes. The RDFs are
defined as the measured distances of all of the membrane-
buried CG atoms of the Ab42 peptide with all of the CG
atoms of the different lipid and sterol components in the
membrane bilayers. To not overwhelm the RDF figures,
we only plot the neutral PC lipid, the charged PS lipid,
and cholesterol interaction profile with the peptide.
Fig. 7 suggests that the primary driving force for the pep-
tide positioning in the membrane is the strong association of
the hydrophobic C-terminus of the peptide with cholesterol.
The loss of cholesterol on the cyto side eventually destabi-
lizes the buried position of the C-terminus in the membrane
seen for 30%/70% and shifts it into the exo leaflet at 40%/
60% and 50%/50% (20%, 40%, and 80% total cholesterol),
and correspondingly drives out the N-terminus of the peptide
to interact with the membrane surface and solvent. The in-
crease in the POPS density is certainly due to the association
of its headgroup with the N-terminus of the peptide, which is
now on or above the membrane surface, and is also
confirmed by the case when cholesterol is eliminated alto-
gether. Because POPC strongly associates with the sterol,its increasing density is tracking the cholesterol association
with the peptide C-terminus. Furthermore, we found that the
peptide-PE lipid RDFs were very similar to the trends seen
for the PC lipid, in which the PE is associating with PC or
cholesterol, but not directly with the peptide itself. In the
Supporting Material we also include a version of Fig. 7 c
with the POPE RDFs included to support this (Fig. S2).DISCUSSION
Various biophysical experiments on Ab interactions with
different lipid environments have shown a strong depen-
dence on cholesterol presence and concentrations that are
consistent with the results presented here. In simple lipid
monolayers and lipid vesicles (i.e., with only a single phos-
pholipid type and/or distributions that are symmetric across
the leaflets) Ab fully inserts only when the cholesterol con-
tent is sufficiently high (46), and Ab has been found to incor-
porate more easily into cholesterol-enriched planar lipid
membranes composed of PC (47). An NMR study of C-99
embedded in LMPG micelles with low cholesterol concen-
trations found that the first 28 residues of this APP fragment
were found in the extracellular space, although the C-termi-
nus was below the membrane surface. In this experiment the
cholesterol concentration in the LMPG micelles was ~5 mol
%, suggesting that the depleted sterol concentration lacks the
hydrophobic driving force for deep insertion of the peptide
into the micelle (48). A neutron diffraction experiment (49)
demonstrated that the helical C-terminal region of the small
fragment Ab25–35was embedded, but the entire peptidewas
unable to fully penetrate lipid bilayers as the cholesterolBiophysical Journal 105(4) 899–910
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FIGURE 4 Free energy profile at 323 K as a function of the distance be-
tween the centers of mass of the 70% helical Ab42 peptide and lipid bilayer
(DCOM), for (a) 20% total cholesterol and (b) 80% total cholesterol, both
symmetrically (50%/50% exo/cyto) distributed across the bilayer, and (c)
with no cholesterol present. When cholesterol is present the free energy
shows that the Ab42 N-terminus is irreversibly exposed to the extracellular
region and to the membrane surface. When no sterol is present, the free en-
ergy profile shows that the Ab42 peptide has a relative free energyminimum
corresponding to the buried peptide (DCOM ~0.5 nm), whereas the dominant
free energy minimum corresponds to collocation of both the N- and C-ter-
minus to the extracellular region and membrane surface (DCOM ~2.5 nm).
FIGURE 5 Images representing a configuration at the global free energy
minimum for (a) the most asymmetric 30%/70% exo/cyto cholesterol dis-
tribution, which shows that the Ab42 peptide (red) prefers to remain well
inserted into the SPM composed of various phospholipids (purple for
POPC headgroups, green for DOPE headgroups, black for POPS head-
groups, and orange phospholipid tails, whereas pink for cholesterol polar
headgroups and yellow for cholesterol tails). (b) The most symmetric
50%/50% exo/cyto cholesterol distribution, which shows that the N-termi-
nus of the Ab42 peptide prefers to exude from the membrane (same color-
ing scheme as (a)). (c) A bilayer with no cholesterol distribution shows that
the Ab42 peptide is only stable on the membrane surface (same coloring
scheme as (a)).
Biophysical Journal 105(4) 899–910
906 Liguori et al.content increased beyond 20% molar ratio. These findings
where confirmed for the same peptide fragment, via electron
paramagnetic resonance spectroscopy on spin-labeled phos-
pholipid acyl tails, which showed that cholesterol, and not
leaflet charge, affects the ability of Ab fragments to insert
(50). Our results are fully consistent with these experimental
studies in that the C-terminus of Ab does embed into the
membrane, but the N-terminus is exposed to the extracellular
space. What we observe is that the Ab peptides insert
completely for the asymmetric cholesterol partitioning,
which is one of the primary results presented here that could
be investigated experimentally.
The results generated with the CG lipid and peptide model
explored here are consistent with all-atom simulations that
also showed that peptide interactions with the membrane
were influenced by cholesterol (45,51), although the all-
atom studies did not investigate cholesterol asymmetry as
ab
c
FIGURE 6 The density profile across the lipid bilayer membrane for
different components of the peptides, sterol, and lipids for: (a) the most
asymmetric 30%/70% exo/cyto cholesterol distribution; (b) the most sym-
metric 50%/50% exo/cyto cholesterol distribution; (c) a bilayer with no
cholesterol. In the legend ROH represents the polar headgroup of choles-
terol. We multiplied the density of the first and last three amino acids
(N-terminus and C-terminus) of the Ab peptide by a factor of 5 to highlight
its positioning with respect to the other bilayer constituents.
Embedding Ab42 in Heterogeneous Membranes 907we have done here. Lemkul and Bevan (51) found that the
C-terminus of Ab40 remained inserted in the lipid bilayer
in the presence of lipid rafts that have cholesterol content.
Our results also agree qualitatively with their observation
that Ab40 remained embedded in simpler lipid bilayers
with no cholesterol (homogeneous POPC and POPS lipid bi-
layers, as well as mixed POPC/POPE membranes) in which
we also observe a free energy minimum, although the lower
free energy state in our model corresponds to the preference
for Ab42 to fully cross the membrane surface and to be fully
solvent exposed. We believe that this discrepancy in the
preferred free energy minimum is most likely due to differ-
ences in the compositions of the membrane systems used in
the previous all-atom simulation studies versus the mem-
brane systems used in our study. Indeed, our study has
shown that different lipid/sterol compositions can make a
qualitative difference in the free energy for peptide stabiliza-
tion within the membrane. As such, one would have to do a
careful calibration study of the same systems using both CG
and all-atom simulations to understand whether the differing
results are due to incomplete sampling of the all-atom
model, differences in the reaction coordinates investigated,
and/or force field issues.
Lemkul and Bevan (51) additionally noted that the Ab40
peptide could lose significant helicity during the course of
their MD simulation runs depending on the proximity of the
C-terminus to themembrane surface. In particular, they found
that the more deeply embedded peptide retained helicity in
the C-terminus, whereas it lost helicity in favor of random
coil structures through interactions with the polar headgroups
on the membrane surface. This is consistent with our CG
model and potentials of mean force for the 70% and 30%
helical Ab42 peptides, because membrane embedding of
theC-terminus requires it to be helical or it will otherwise pre-
fer the membrane surface. Although other studies may define
embedding as having any portion of theAb42beingbelow the
membrane-solvent surface, our results are far more quantita-
tive by providing the free energy at any position of the Ab42
peptide inside or outside the lipid bilayer.CONCLUSIONS
We have computed relative free energies for the process of
release of Ab42 to the extracellular region from an
embedded position inside planar lipid bilayers that are
modeled on realistic rodent SPM lipid/sterol compositions
(20), and which are compared as a function of age-depen-
dent cholesterol redistributions across the bilayer (15). We
showed that the reduced concentrations of cholesterol in
the exo leaflet of young neuronal cells favors membrane
retention of the highly reactive N-terminus region of the
Ab peptide, whereas age-dependent increases in the choles-
terol content of the exo leaflet favor secretion of the first 28
residues of Ab42 peptide into the extracellular space. Loss
of helicity in the C-terminus of the Ab42 peptide and modelBiophysical Journal 105(4) 899–910
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FIGURE 7 The radial distribution function of the
Ab peptide with different lipid and sterol compo-
nents for: (a) the most asymmetric 30%/70% exo/
cyto cholesterol distribution with total cholesterol
of 40%; (b) the 40%/60% exo/cyto cholesterol dis-
tribution with total cholesterol of 40%; (c) the sym-
metric 50%/50% exo/cyto cholesterol distribution
with total cholesterol of 40%; (d) no cholesterol.
The symmetric 50%/50% exo/cyto cholesterol dis-
tribution with total cholesterol of (e) 20% and (f)
80%, in which the high cholesterol concentration
in the membrane is found to be a crystalline ordered
phase.
908 Liguori et al.membranes not including cholesterol were found to be the
least favorable domains for the membrane retention of the
peptide, thereby contributing to the substantial binding of
Ab42 to the exo surface of the membrane.
In summary, this work has shown that a new, to our
knowledge, membrane variable—cholesterol asymmetry—
has a significant influence on the free energy of release of
the virulent Ab42 species into the extracellular space.
Furthermore, we emphasize that the helicity of the C-termi-
nus of the Ab42 peptide is critical for its retention. Our
results and those generated by others show that the
complexity of the lipid bilayer composition, the spatial dis-
tributions of lipids and sterol (or rafts), combined with the
length, protonation states, and secondary structure of the
peptide, all have influence on the stabilization of the disease
peptide in the membrane. Thus, membrane influences that
favor peptide unfolding at the C-terminus or extrusion of
the highly reactive N-terminus into the extracellular space
may result in vulnerability for aggregation, oligomerization,
or deleterious oxidative reactivity. The repositioning of theBiophysical Journal 105(4) 899–910amyloid peptide in the membrane as individual ages could
also result in changing the position for the cleavage site of
secretases that might favor the amyloidogenic pathway.SUPPORTING MATERIAL
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